Abstract
The annual Hajj pilgrimage in Mecca, Saudi Arabia, attracts millions of Muslims from around the world, creating a unique mass gathering (MG). The World Health Organization has expressed concerns regarding unsafe pharmaceutical practices and medication errors, emphasizing the importance of addressing medication safety in high-risk environments. During the Hajj, nurses are responsible for preparing intravenous (IV) medications, which may increase the potential for medication preparation errors. This review seeks to underscore the critical measures necessary for ensuring medication safety when handling IV medications in critical care settings during Hajj MGs. Furthermore, the review proposes a streamlined guide for the preparation and dosage of IV critical care medications, including antidotes, to support healthcare providers in maintaining medication safety throughout the Hajj. By adopting these recommendations, healthcare professionals can significantly improve the safety and overall well-being of pilgrims participating in the Hajj pilgrimage.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.